Screening for Substance Use Disorders/Opioid Use Disorder

This manual provides counselors with an overview of the Family Education component of the Matrix Intensive Outpatient Treatment for People with Stimulant Use Disorders (IOP) package and general guidelines for conducting sessions.

A Protocol using empirically-supported behavioral treatments for people with psychoactive stimulant use disorders. There are manuals for healthcare professionals who provide treatment services for individuals with psychoactive substance use disorder (PSUD) and for patients who are entering PSUD treatment.

This “how-to” guide provides physician practices and health systems with practical strategies, actionable steps and evidence-based resources for identifying and addressing unhealthy substance use or misuse in their patients.

This paper offers principle and recommendations for remediating the impacts of the rising rates of drugs adulterated or laced with fentanyl.

The Health Resources & Services Administration funded Substance Use Warmline (855-300-3595, nccc.ucsf.edu) is pleased to offer confidential, free teleconsultation to clinicians on substance use evaluation and management

One of SAMHSA's series of advisories based on TIP 31, which includes recommendations for engaging adolescents in substance use disorder risk assessment, screening, and treatment

Website designed to impact patient outcomes positively in the realm of substance use by providing effective training in SBIRT skills for healthcare providers

Report concludes that offering SBIRT in emergency department settings produces overall cost savings

Provides general information about telehealth, changes to policies during COVID-19, planning telehealth workflows, preparing patients for telehealth visits, billing and reimbursement, legal considerations, privacy and security, telehealth vendors and platforms, and best practices

Describes a screening system and workflow developed for primary care and behavioral health integration in a rural clinic that involves use of tablets and a provider alert in the electronic health record